Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 4 1Phase 2 1

Status

Recruiting 8Not yet recruiting 2Enrolling by invitation 2Completed 2Active not recruiting 2Terminated 1

Sponsor Class

OTHER 8

Study Type

Observational 4Interventional 4

Sponsor

Cancer Type

Breast 4Other hematologic neoplasm 1

Conditions

Breast Neoplasms 529Neoplasms 475Carcinoma, Non-Small-Cell Lung 394Prostatic Neoplasms 308Colorectal Neoplasms 296Lung Neoplasms 259Neoplasm Metastasis 218Ovarian Neoplasms 200Leukemia, Myeloid, Acute 199Pancreatic Neoplasms 187Multiple Myeloma 175Squamous Cell Carcinoma of Head and Neck 134Recurrence 132Stomach Neoplasms 131Brain Neoplasms 126Carcinoma, Hepatocellular 125Melanoma 124Endometrial Neoplasms 122Glioblastoma 118Triple Negative Breast Neoplasms 111Precursor Cell Lymphoblastic Leukemia-Lymphoma 106Hematologic Neoplasms 100Head and Neck Neoplasms 99Lymphoma 97Carcinoma, Renal Cell 97Urinary Bladder Neoplasms 93Sarcoma 90Glioma 88Lymphoma, Non-Hodgkin 82Rectal Neoplasms 81

Interventions

Environmental Biomarkers 1Echocardiography 1Blood Pressure Determination 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

8 trials
RecentStart dateEnrollment
Recruiting × Cardiotoxicity × 90 days × Clear all
NCT02772367 2026-06-03

Generation of Heart Muscle Cells From Blood or Skin Cells of Breast Cancer Patients

Memorial Sloan Kettering Cancer Center

Recruiting
120 enrolled
Breast

Breast Neoplasms, Cardiotoxicity

NCT03790943 2026-05-29

Cardio-Onco

University of Bern

Recruiting
500 enrolled

Cardiovascular Diseases, Neoplasms, Cardiotoxicity

NCT06023576 2026-05-14

A Study of Blood Pressure Control During Cancer Treatment

Memorial Sloan Kettering Cancer Center

Phase 2 Recruiting
130 enrolled
Breast

Breast Neoplasms, Cardiotoxicity

NCT05598879 2026-05-12

G-COR

The Cleveland Clinic

Recruiting
5,000 enrolled
BreastOther hematologic neoplasm

Breast Neoplasms, Cardiovascular Diseases, Hematologic Neoplasms, Cardiotoxicity

NCT07528586 2026-04-14

CMR-Onko

Robert Bosch Gesellschaft für Medizinische Forschung mbH (RBMF)

Phase NA Recruiting
93 enrolled

Cardiotoxicity

NCT06183437 2026-03-30

STOP-MED CTRCD

University Health Network, Toronto

Phase 4 Recruiting
335 enrolled

Heart Failure, Neoplasms, Cardiotoxicity

NCT06778122 2026-03-27

BREATHS

University College, London

Phase NA Recruiting
10 enrolled

Inflammation, Cardiotoxicity

NCT07191730 2026-03-19

ML-CardioTox

University Hospital, Caen

Recruiting
600 enrolled
Breast

Breast Neoplasms, Heart Failure, Neoplasms, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡